Skip to main content
SpringerLink
Log in

Is there a role for the tumor cell integrin αIIbβ3 and cytoskeleton in tumor cell-platelet interaction?

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

In vitro tumor cell-platelet interaction was examined using B16 amelanotic (B16a) melanoma cells. These tumor cells express the αIIbβ3-type cytoadhesin. Aggregation studies demonstrated that tumor cell surface αIIbβ3 mediates the recognition of platelets since pretreatment of tumor cells with antibody against αIIbβ3 prevents platelet-tumor cell interaction as well as platelet activation measured by aggregometry, platelet eicosanoid metabolism and ultrastructural analysis. In B16a cells, disruption of the microfilaments and intermediate filaments inhibits mobility of αIIbβ3 on the cell surface. Microtubules do not play a role in receptor mobility, because B16a cells do not possess well-defined microtubules in interphase and colchicine does not affect receptor mobility. Disruption of microfilaments or intermediate filaments results in an inhibition of tumor cell-platelet interaction as evidenced by aggregometry studies and ultrastructural analysis. We suggest that platelet interaction with tumor cells begins with αIIbβ3-mediated receptor recognition followed by not only platelet activation but also microfilament- and vimentin intermediate filament-dependent tumor cell activation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Crissman JD, Hatfield J, Schaldenbrand M, Sloane BF and Honn KV, 1985, Arrest and extravasation of B16 amelanotic melanoma in murine lungs. Laboratory Investigations, 53, 470–478.

    Google Scholar 

  2. Honn KV, Cavanaugh PG, Crissman JD, Taylor JD and Sloane BF, 1986, Platelet-tumor cell interactions as a target for antimetastatic therapy. In: Honn KV, Powers WE and Sloane BF, eds. Mechanisms of Cancer Metastasis. Potential Therapeutic Implications, pp. 117–144. Boston: Martinus Nijhoff Publishing.

    Google Scholar 

  3. Crissman JD, Hatfield JS, Menter DG, Sloane BF and Honn KV, 1988, Morphological study of the interaction of intravascular tumor cells with endothe lial cells and subendothelial matrix. Cancer Research, 48, 4065–4072.

    Google Scholar 

  4. Menter DG, Hatfield JS, Harkins CJ, Sloane BF, Taylor JD, Crissman JD and Honn KV, 1987, Tumor cell-platelet interactions in vitro and their relationship to in vivo arrest of hematogenously circulating tumor cells. Clinical and Experimental Metastasis, 5, 65–78.

    Google Scholar 

  5. Menter DG, Sloane BF, Steinert BW, Onoda J, Craig R, Harkins C, Taylor JD and Honn KV, 1987, Platelet enhancement of tumor cell adhesion to subendothelial matrix. Role of platelet cytoskeleton and platelet membrane. Journal of the National Cancer Institute, 79, 1077–1090.

    Google Scholar 

  6. Honn KV, Grossi IM, Diglio CA, Wojtukiewicz M and Taylor JD, 1989, Enhanced tumor cell adhesion to the subendothelial matrix resulting from 12(S) HETE-induced endothelial cell retraction. FASEB Journal, 3, 2285–2293.

    Google Scholar 

  7. Honn KV, Grossi IM, Timar J, Chopra H and Taylor JD, 1991, Platelets and cancer metastasis. In: Orr W, Buchanan M and Weiss L, eds. Microcirculation and Cancer Metastasis, pp. 93–110. Boca Raton, FL: CRC Press.

    Google Scholar 

  8. Chopra H, Hatfield JS, Chang SY, Grossi IM, Fitzgerald LA, O'Gara CY, Marnett LJ, Diglio CA, Taylor JD and Honn KV, 1988, Role of tumor cell cytoskeleton and membrane glycoprotein IRGpIIb/ IIIa in platelet adhesion to tumor cell plasma membrane and tumor cell induced platelet aggregation. Cancer Research, 48, 3787–3800.

    Google Scholar 

  9. Honn KV, Menter DG, Onoda JM, Taylor JD and Sloane BF, 1984, Role of prostacyclin as a natural deterrent to hematogenous tumor metastasis. In: Nicolson G and Milas L, eds. Cancer Invasion and Metastasis, pp. 361–388. New York: Raven Press.

    Google Scholar 

  10. Bastida E, Almirall L and Ordinas A, 1987, Tumor cell-induced platelet aggregation is a glycoprotein dependent and lipoxygenase-associated process. International Journal of Cancer, 39, 760–763.

    Google Scholar 

  11. Grossi IM, Fitzgerald LA, Kendall A, Taylor JD, Sloane BF and Honn KV, 1987, Inhibition of human tumor cell induced platelet aggregation by antibodies to platelet glycoproteins Ib and IIb/IIIa. Proceedings of the Society of Experimental Biology and Medicine, 186, 378–383.

    Google Scholar 

  12. Bourkereche H, Berthier-Vergnes O, Tabone E, Dore' J, Leung LLK and McGregor JL, 1989, Platelet-melanoma cell interaction is mediated by the glycoprotein IIb-IIIa complex. Blood, 74, 658–663.

    Google Scholar 

  13. Grossi IM, Hatfield JS, Fitzgerald LA, Newcombe M, Taylor JD and Honn KV, 1988, Role of tumor cell glycoproteins immunologically related to glycoproteins Ib and IIb/IIIa in tumor cell-platelet and tumor cell-matrix interactions. FASEB Journal, 2, 2385–2395.

    Google Scholar 

  14. Grossi IM, Fitzgerald LA, Umbarger LA, Nelson KK, Diglio CA, Taylor JD and Honn KV, 1989, Bidirectional control of membrane expression and/or activation of the tumor cell IRGpIIb/IIIa receptor and tumor cell adhesion by lipoxygenase products of arachidonic acid and linoleic acid. Cancer Research, 49, 1029–1037.

    Google Scholar 

  15. McGregor BC, McGregor JL, Weiss LM, Wood GS, Hu CH, Bourkereche H and Warnke RA, 1989, Presence of cytoadhesins (IIb-IIIa-like glycoproteins) on human metastatic melanomas but not on benign melanocytes. American Journal of Clinical Pathology, 92, 495–499.

    Google Scholar 

  16. Chang SY, Chen YQ, Fitzgerald LA, Honn KV, 1991, Analysis of integrin mRNA in human and rodent tumor cells. Biochemical and Biophysical Research Communications, 176, 108–113.

    Google Scholar 

  17. Chropra H, Timar J, Chen YQ, Rong X, Grossi IM, Fitzgerald LA, Taylor JD and Honn KV, 1991, The lipoxygenase metabolite 12-(S)-HETE induces a cytoskeleton dependent increase in surface expression of integrin αIIbβ3 on melanoma cells. International Journal of Cancer, 49, 774–786.

    Google Scholar 

  18. Timar J, Chopra H, Rong X, Hatfield JS, Fligiel SEG, Onoda JM, Taylor JD and Horn KV. Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin αIIbβ3 and tumor cell-induced platelet aggregation. Journal of Cancer Research and Clinical Oncology, in press.

  19. Katagiri Y, Hayashi Y, Baba I, Suzuki H, Tanoue K and Yamazaki H, 1991, Characterization of platelet aggregation induced by the human melanoma cell line HMV-1: roles of heparin, plasma adhesive proteins and tumor cell membrane proteins. Cancer Research, 51, 1286–1293.

    Google Scholar 

  20. Chopra H, Fligiel SEG, Hatfield JS, Nelson KK, Diglio CA, Taylor JD, Honn KV, 1990, An in vivo study of the role of the tumor cell cytoskeleton in tumor cell-platelet interaction. Cancer Research, 50, 7686–7696.

    Google Scholar 

  21. Coller BS, Peerschke EI, Scudder LE and Sullivan CA, 1983, A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets and produces a thrombasthenic-like state in normal platelets and binds to glycoprotein IIb and/or IIIa. Journal of Clinical Investigations, 72, 325–338.

    Google Scholar 

  22. Pidard D, Montgomery RR, Bennett JS and Kunicky TJ, 1983, Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets. Journal of Biological Chemistry, 258, 12582–12586.

    Google Scholar 

  23. Menter DG, Steinert BW, Sloane BF, Taylor JD and Honn KV, 1987, A new in vitro model for investigation of tumor cell-platelet-endothelial cell interaction and concomitant eicosanoid biosynthesis. Cancer Research, 47, 2425–2432.

    Google Scholar 

  24. Hamberg M and Samuelsson B, 1974, Prostaglandin endoperoxides: novel transformations of arachidonic acid in human platelets. Proceedings of the National Academy of Sciences, U.S.A., 71, 3400–3404.

    Google Scholar 

  25. Honn KV, Steinert BW, Moin K, Onoda JM, Taylor JD and Sloane BF, 1987, The role of platelet cyclooxygenase and lipoxygenase pathways in tumor cell induced platelet aggregation. Biochemical and Biophysical Research Communications, 145, 384–389.

    Google Scholar 

  26. Ben-Ze'ev A and Raz A, 1985, Relationship between the organization and synthesis of vimentin and the metastatic capability of B16 melanoma cells. Cancer Research, 45, 2632–2641.

    Google Scholar 

  27. Cavanaugh PG, Sloane BF and Honn KV, 1988, Role of the coagulation system in tumor cell-induced platelet aggregation and metastasis. Haemostasis, 18, 37–46.

    Google Scholar 

  28. Gordon S and Cross B, 1981, A factor X-activating cysteine proteinase from malignant tissue. Journal of Clinical Investigations, 67, 1665–1671.

    Google Scholar 

  29. Broze GJ, Leykam JE, Schwarz BD, Miletich H, 1985, Purification of human brain tissue factor. Journal of Biological Chemistry, 260, 10917–10920.

    Google Scholar 

  30. Chelladurai M, Honn KV, Waltz DA, 1991, HLA-DR is a procoagulant. Biochemical and Biophysical Research Communications, 178, 467–473.

    Google Scholar 

  31. Karpatkin S, Pearlstein E, Ambrogio C and Coller BS, 1988, Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. Journal of Clinical Medicine, 81, 1012–1019.

    Google Scholar 

  32. Cheresh DA, Berliner SA, Vicente V and Ruggeri ZM, 1989, Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell, 58, 945–953.

    Google Scholar 

  33. Plow EF, Ginsberg MH and Marguerie GA, 1986, Expression and function of adhesive proteins on the platelet surface. In: Phillips DR and Shuman A, eds. Biochemistry of Platelets, pp. 160–225. Orlando, FL: Academic Press.

    Google Scholar 

  34. Akiyama SK, Nagata K and Yamada KM, 1990, Cell surface receptors for extracellular matrix components. Biochimica et Biophysica Acta, 1031, 91–110.

    Google Scholar 

  35. Hynes RO, 1987, Integrins: a family of cell surface receptors. Cell, 48, 549–554.

    Google Scholar 

  36. Ruoslahti E and Pierschbacher MD, 1987, New perspectives in cell adhesion: RDG and integrins. Science, 238, 491–497.

    Google Scholar 

  37. Timar J, Chopra H, Grossi IM, Taylor JD and Honn KV, 1991, The lipoxygenase metabolite of arachidonic acid 12-(S)-HETE induces cytoskeleton dependent upregulation of integrin αIIbβ3 in melanoma cells. In: Honn KV, Marnett LJ, Nigam S and Walden T, eds. Eicosanoids and Other Bioactive Lipids in Cancer and Radiation Injury, pp. 331–346. Boston: Kluwer Acad. Publ.

    Google Scholar 

  38. Schafer AI, Takayama H, Farrell S and Gimborne MA Jr, 1986, Incorporation of platelet and leukocyte lipoxygenase metabolites by cultured vascular cells. Blood, 67, 373–378.

    Google Scholar 

  39. Honn KV, Grossi IM, Fitzgerald LA, Umbarger LA, Diglio CA and Taylor JD, 1988, Lipoxygenase products regulate IRGpIIbIIIa receptor mediated adhesion of tumor cells to endothelial cells, subendothelial matrix and fibronectin. Proceedings of the Society of Experimental Biology and Medicine, 189, 130–135.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, VA Medical Center, 48101, Allen Park, MI, USA

    James S. Hatfield, Suzanne E. G. Fligiel & John D. Taylor

  2. Department of Radiation Oncology, Wayne State University, 48202, Detroit, MI

    Hemi Chopra, Jozsef Timar, X. Rong, Irma M. Grossi & Kenneth V. Honn

  3. Department of Biological Sciences, Wayne State University, 48202, Detroit, MI, USA

    Catherine A. Finch & John D. Taylor

  4. Gershenson Radiation Oncology Center, 48201, Detroit, MI, USA

    John D. Taylor & Kenneth V. Honn

  5. Department of Biological Chemistry, School of Medicine, Johns Hopkins University, 21205, Baltimore, MD, USA

    Hemi Chopra

  6. Bristol Meyers Squibb Co., 06492-7660, Wallington, CT, USA

    Irma M. Grossi

Authors
  1. Hemi Chopra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jozsef Timar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. X. Rong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Irma M. Grossi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. James S. Hatfield
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Suzanne E. G. Fligiel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Catherine A. Finch
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. John D. Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kenneth V. Honn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chopra, H., Timar, J., Rong, X. et al. Is there a role for the tumor cell integrin αIIbβ3 and cytoskeleton in tumor cell-platelet interaction?. Clin Exp Metast 10, 125–137 (1992). https://doi.org/10.1007/BF00114589

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00114589

Keywords

Search

Navigation